2006 annual financial data
GT Biopharma 2006 Operating margin
Direct answer
Operating margin was -46.23%.
Operating income was -2,670,000 USD and net income was -4,940,000 USD.
Operating cash flow was -671,000 USD.
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,776,000 USD
- Operating income
- -2,670,000 USD
- Net income
- -4,940,000 USD
- Operating cash flow
- -671,000 USD